Literature DB >> 7251147

Immune defenses against Legionella pneumophila in rats.

B Rolstad, B P Berdal.   

Abstract

Rats were examined for their susceptibility to infection with Legionella pneumophila. Different strains of L. pneumophila representing serogroups 1 to 4 were tested (Philadelphia 1 and 2, Togus 1, Bloomington 2, Los Angeles 1, and the recently isolated LD-8 from the epidemics in Västeraas, Sweden). When about 9 x 10(8) bacteria, or 6 x 10(8) colony-forming units, were injected intraperitoneally, only rats infected with the LD-8 strain showed signs of illness. They became ill within 4 to 6 h and usually died within 24 h with septicemia and signs of circulatory collapse. Bacteria killed by heating at 100 degrees C for 15 min lost their pathogenicity. Rats that were preimmunized with the Philadelphia 1 strain (same serogroup as LD-8), regardless of the route of immunization (subcutaneous, intraperitoneal, or intravenous), developed resistance to subsequent infection with LD-8. This resistance was serogroup specific and could be passively transferred to nonimmune animals with syngeneic immune serum or immunoglobulin fractions of serum. Antiserum or gamma globulin-enriched serum fractions from sheep with specificity for the Philadelphia 1 or Togus 1 strains also protected rats from the lethal effect of strain LD-8. The kinetics of the antibody and blood leukocyte response to immunization with the Philadelphia 1 strain of L. pneumophila in normal rats was investigated. During week 1 after intravenous injection the rats developed a marked lymphocytosis, which lasted for at least 1 week. The antibody response, as measured by indirect immunofluorescence or by a modification of the microagglutination method which we describe here, reached a peak during week 2 after immunization. Splenectomized rats were also resistant to infection with the Philadelphia 1 strain, but their antibody responses were substantially lower than those of their sham-operated littermates.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7251147      PMCID: PMC351516          DOI: 10.1128/iai.32.2.805-812.1981

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  13 in total

1.  The alloantibody response to a strong transplantation antigen (Ag-B). Quantitative aspects and thymus dependence of the response.

Authors:  B Rolstad; A F Williams; W L Ford
Journal:  Transplantation       Date:  1974-04       Impact factor: 4.939

2.  Protein A from Staphylococcus aureus. Its isolation by affinity chromatography and its use as an immunosorbent for isolation of immunoglobulins.

Authors:  H Hjelm; K Hjelm; J Sjöquist
Journal:  FEBS Lett       Date:  1972-11-15       Impact factor: 4.124

3.  Four serogroups of Legionnaires' disease bacteria defined by direct immunofluorescence.

Authors:  R M McKinney; L Thacker; P P Harris; K R Lewallen; G A Hebert; P H Edelstein; B M Thomason
Journal:  Ann Intern Med       Date:  1979-04       Impact factor: 25.391

4.  Immunochemical, serologic, and immunologic properties of major antigens isolated from the Legionnaires' disease bacterium. Observations bearing on the feasibility of a vaccine.

Authors:  K H Wong; W O Schalla; R J Arko; J C Bullard; J C Feeley
Journal:  Ann Intern Med       Date:  1979-04       Impact factor: 25.391

5.  Immunologic factors affecting the in-vivo and in-vitro survival of the Legionnaires' disease bacterium.

Authors:  R J Arko; K H Wong; J C Feeley
Journal:  Ann Intern Med       Date:  1979-04       Impact factor: 25.391

6.  Detection of antibodies to legionnaires disease organism by microagglutination and micro-enzyme-linked immunosorbent assay tests.

Authors:  C E Farshy; G C Klein; J C Feeley
Journal:  J Clin Microbiol       Date:  1978-04       Impact factor: 5.948

7.  Virulent to avirulent conversion of Legionnaires' disease bacterium (Legionella pneumophila)--its effect on isolation techniques.

Authors:  J E McDade; C C Shepard
Journal:  J Infect Dis       Date:  1979-06       Impact factor: 5.226

8.  Determination of the optimal ammonium sulfate concentration for the fractionation of rabbit, sheep, horse, and goat antisera.

Authors:  G A Hebert; P L Pelham; B Pittman
Journal:  Appl Microbiol       Date:  1973-01

9.  Immunologic protection against the Legionnaires' disease bacterium in the AKR/J mouse.

Authors:  K W Hedlund; V G McGann; D S Copeland; S F Little; R G Allen
Journal:  Ann Intern Med       Date:  1979-04       Impact factor: 25.391

10.  "Endotoxicity" of the Legionnaires' disease bacterium.

Authors:  K H Wong; C W Moss; D H Hochstein; R J Arko; W O Schalla
Journal:  Ann Intern Med       Date:  1979-04       Impact factor: 25.391

View more
  5 in total

1.  Intracellular growth in Acanthamoeba castellanii affects monocyte entry mechanisms and enhances virulence of Legionella pneumophila.

Authors:  J D Cirillo; S L Cirillo; L Yan; L E Bermudez; S Falkow; L S Tompkins
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

2.  Identification of protein antigens of Legionella pneumophila serogroup 1.

Authors:  E Pearlman; N C Engleberg; B I Eisenstein
Journal:  Infect Immun       Date:  1985-01       Impact factor: 3.441

Review 3.  Legionnaires disease: historical perspective.

Authors:  W C Winn
Journal:  Clin Microbiol Rev       Date:  1988-01       Impact factor: 26.132

4.  Relative potency of virulent versus avirulent Legionella pneumophila for induction of cell-mediated immunity.

Authors:  T W Klein; H Friedman; R Widen
Journal:  Infect Immun       Date:  1984-06       Impact factor: 3.441

5.  Cellular immunity to Legionella pneumophila in guinea pigs assessed by direct and indirect migration inhibition reactions in vitro.

Authors:  H Friedman; R Widen; I Lee; T Klein
Journal:  Infect Immun       Date:  1983-09       Impact factor: 3.441

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.